IceCure Medical (NASDAQ:ICCM) and DENTSPLY SIRONA (NASDAQ:XRAY) Head-To-Head Review
by Sarita Garza · The Markets DailyDENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) and IceCure Medical (NASDAQ:ICCM – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, risk, earnings, analyst recommendations and profitability.
Institutional and Insider Ownership
95.7% of DENTSPLY SIRONA shares are owned by institutional investors. Comparatively, 0.6% of IceCure Medical shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by insiders. Comparatively, 2.4% of IceCure Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Valuation and Earnings
This table compares DENTSPLY SIRONA and IceCure Medical”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| DENTSPLY SIRONA | $3.68 billion | 0.46 | -$598.00 million | ($2.75) | -3.07 |
| IceCure Medical | $3.38 million | 1.06 | -$15.06 million | ($8.52) | -0.12 |
IceCure Medical has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
DENTSPLY SIRONA has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500. Comparatively, IceCure Medical has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500.
Profitability
This table compares DENTSPLY SIRONA and IceCure Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| DENTSPLY SIRONA | -14.99% | 20.84% | 5.32% |
| IceCure Medical | -427.67% | -174.26% | -112.58% |
Analyst Ratings
This is a breakdown of current ratings and recommmendations for DENTSPLY SIRONA and IceCure Medical, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| DENTSPLY SIRONA | 3 | 8 | 3 | 0 | 2.00 |
| IceCure Medical | 1 | 1 | 2 | 0 | 2.25 |
DENTSPLY SIRONA currently has a consensus price target of $12.92, suggesting a potential upside of 53.12%. IceCure Medical has a consensus price target of $30.00, suggesting a potential upside of 2,784.62%. Given IceCure Medical’s stronger consensus rating and higher probable upside, analysts clearly believe IceCure Medical is more favorable than DENTSPLY SIRONA.
Summary
DENTSPLY SIRONA beats IceCure Medical on 8 of the 13 factors compared between the two stocks.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina
About IceCure Medical
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.